close

Sun Pharma nears 52-week high ahead of Q3 results; stock up 7% in a month

In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex

SI Reporter Mumbai
Sun Pharma
Premium

Shares of Sun Pharmaceutical Industries gained 2.5 per cent to Rs 1,069.40 in Monday’s intra-day trade and quoted close its 52-week high level ahead of the December quarter results (Q3FY23) due Tuesday, January 31, 2023. In comparison, the S&P BSE Sensex was down 0.24 per cent at 59,185 at 11:17 am. The stock of healthcare company had hit 52-week high of Rs 1,071 on November 2, 2022. In the past one month, it outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex. The stock had hit a record high of Rs 1,201 on April 7, 2015.
Or

Also Read

Sun Pharma stock likely to keep shining amid global specialty scale-up

Sun Pharma Q2 PAT rises 10.5% YoY to Rs 2,262 crore on robust sales

Sun Pharma extends gains post September quarter earnings; up 6% in two days

Specialty drugs may push Sun Pharma's US biz beyond $2 bn by 2025

We thrive on products that have limited competition: Top Sun Pharma execs

Rail Vikas, Titagarh: Bullish trend in railway-related stocks may continue

Adani rebuttal to Hindenburg fails to stem concern, bond plunge quickens

Bajaj Finance surges 5% on record quarterly profit

Data Patterns surges 13% on strong Q3 results, healthy order book position

Adani Enterprises zooms 10% post clarification, other group stocks mixed

Sun Pharma.Inds.

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y
  • MAX

First Published: Jan 30 2023 | 11:56 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com